EndoStim has raised $14.1 million in a fundraising round, according to a St. Louis Business Journal report.

EndoStim is a St. Louis, Mo.- and Amsterdam, The Netherlands-based medical device company focused on developing products for the treatment of gastroesophageal reflux disease (GERD).

VC funds made up about 40 percent of the funding, with investors including Santé Ventures, Voyent Partners and Prolog Ventures and Vectis Healthcare & Life Sciences Fund II.